home > news > detailed info

TrialScope Taps Industry Veteran as CTO


TrialScope Taps Industry Veteran as CTO, Expanding Its Management Team

JERSEY CITY, NJ, July 29, 2019 – TrialScope, the global leader in clinical trial transparency and compliance solutions, announces the appointment of Ruben Echandy as Chief Technology Officer.

TrialScope CEO Ruben Echandy“In the clinical and health market, there’s informational chaos. There’s an opportunity for TrialScope to bring visibility, trust and distill further intelligence from that data,” said Echandy. “I also believe a patient deserves a higher level of hyper-personalization from life science technologies, more control over his/her pathology. TrialScope has a strong opportunity to champion this.”

“Life science technology is fast paced and constantly evolving,” said TrialScope CEO Jeff Kozloff. “Ruben’s technical leadership, coupled with his business acumen, make him the ideal fit for TrialScope and our technology team.” Kozloff added that Echandy has a proven track record of attracting and inspiring top talent in all aspects of software delivery life cycles.

In his role as CTO at TrialScope, Echandy sees himself as an evangelist for vision and innovation, using strategic thinking to anticipate emerging market trends. As with any TrialScope undertaking, the desired end result is improved overall customer satisfaction and utility of its products. To that end, Echandy said his goal is to promote a close proximity between customers and engineering, propelling business forward, accelerating TrialScope’s market footprint and adoption of innovation. The key to fostering long-lasting relationships with clients, he said, is “to carefully listen to our customers, and to always be truthful.”

Echandy says he is looking forward to working on new technologies and working with his IT team. “The level of professionalism and utmost dedication to advance the company’s mission was palpable in every conversation I’ve had with Jeff Kozloff and with every member of his executive team."

Kozloff echoes staffers’ excitement at this new addition to the TrialScope team. “At TrialScope, we continuously reinvest in our software platform,” said Kozloff. “To do so effectively, we must also invest in the expertise behind these market-leading compliance and patient engagement solutions. This is why I am extremely pleased to have Ruben lead our tech group. I am confident that, in his hands, we will make even greater strides with our technology, enabling our clients to expand upon their commitments to clinical trial disclosure, data sharing and transparency.”

Over the last 14 years, Echandy has managed both small and large teams at well-respected engineering organizations. Having led global teams through a variety of challenges, Echandy said he is ready to accelerate on every sharp corner that comes his way. Prior to joining TrialScope, Echandy served as Senior Director of Engineering at Medidata Solutions, a software company also catering to the pharmaceutical industry. His previous positions include serving as Senior Consultant for several IT firms and as Vice President of Engineering at Digital Guardian.

“I enjoy accelerating growth companies,” said Echandy, “and am fearless in charging forward.”

For more information on TrialScope, visit

About TrialScope
TrialScope is the global leader in clinical trial disclosure and transparency management technology, supporting 13 of the top 15 industry clinical trial sponsors worldwide. TrialScope provides proven solutions that optimize the efficiency of disclosure activities, maximize trial data transparency, and foster more informed, engaged patients through open research sharing. To learn more about TrialScope, visit
phone 1-877-658-8310
web www.
email 185 Hudson Street, Suite 2900
Print this page
Send to a friend
News and Press Releases

Signant Health Senior Vice President Dr. David Daniel Honored in PharmaVOICE 100

Philadelphia, PA – August 1, 2019: Signant Health (formerly CRF Health and Bracket) today announces that its Senior Vice President, Dr. David Daniel, has been selected by PharmaVOICE as one of the top 100 most inspiring people within the life sciences sector. Dr. Daniel was selected from a large cross section of established professionals in the life sciences industry for his passion to continually improve the way in which science, technology and service interact. This honor swiftly follows another recent mark of distinction for Dr. Daniel, having been co-awarded the 2019 ISCDD Scientific Leadership Award.
More info >>

White Papers

Clinical Trials in Russia Orange Paper: 2nd Quarter 2014

Synergy Research Group

The Ministry of Health of Russian Federation approved 194 new clinical trials of all types including local and bioequivalence studies during the 2nd Quarter of 2014 (3% less than at the same period of the last year). The main contribution to the total number of studies was made by multinational multi-center clinical trials (MMCT) and the number of these studies stayed the same as in Q2 2013 – 81 studies. The number of bioequivalence studies (BE) decreased from 76 studies in Q2 2013 to 59 in Q2 2014, a 22% decrease from last year’s figure. The number of local clinical trials (LCT) increased from 42 in Q2 2013 to 54 clinical trials in Q2 2014.
More info >>

Industry Events

SCOPE Europe – Summit for Clinical Ops Executives Europe

17-18 September 2019, Barcelona, Spain

Building on the success of its long-running US-based counterpart, Summit for Clinical Trials Operations Executives Europe (SCOPE Europe) is a two-day event serving clinical innovation leaders, clin ops execs, functional heads, category managers, and those responsible for the planning and management of clinical trials in Europe and the Rest of the World. The event will feature opening and closing plenary keynote sessions, five conference tracks, interactive breakout discussion groups, and networking. It is an opportunity for leaders from large, mid-sized, and small pharma, specialty pharma, biotech, vendor companies, and academic research centers to come together to share best practices and discuss the new era of analytics-driven and patient-centric trials.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement